74 Actions to Take For the Earnings Shakeout

Earnings season has kicked into high gear, and here is how to stay ahead of these 74 stocks More 

Ugly Fight at Obesity Drug Company Leads to New CEO

Vivus will settle a proxy battle with its largest shareholder by adding six board members and a new CEO backed by First Manhattan. More 

Study: Prilosec, Nexium, Prevacid May Lead to Heart Disease

A study by John P. Cooke published in American Heart Association journal, Circulation, links drugs like Prilosec and Prevacid to heart disease. More 

2 Major Pharmaceutical Rivals to Share Drug Data

AstraZeneca and Roche will share drug research data with a third company to build a compound library to accelerate drug development and lower costs. More 

3 Ways to Play the M&A Wave

Want to get in on Wall Street's wheeling and dealing without taking on the risk of gambling on the next buyout target? Try these three options instead. More 

Is M&A Mania Poised to Keep Fanning the Market’s Flames?

America's renewed push of merger & acquisition action has the potential to drive market optimism and help buoy stocks -- but which stocks, and for how long? More 

Merger Monday: Who’s the Big Winner?

Google, AstraZeneca and IHS all made headline-grabbing M&A news today, but one of them stands out above the others. More